Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (819)	2/14/2005 3:50:36 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CPHD Is trading above its Dec.3 H on expanding volume. (Already more than 553Ks. but still below the 642,799 traded on Jan.25) If the stock can close above the Dec. H at 10.74 the next resistance seems to be the Jul. H at 11.74 the Jan.2004 H at 13.56 looks somewhat far and to get there it will probably need some more good news.<g> bigcharts.marketwatch.com CPHD has continued to report better sequential revenues which look even better when compared to the previous year.<g> The loss for 2004 is expected around $0.33/share vs. $0.53/share in 2003 and for 2005 the loss has been estimated around $0.11/share. It reportedly has around 58.24M in cash, almost $1.40/share and its Debt/Equity Ratio is around:0.22 It has been spending a substantial amount in R&D (close to 80% of revenues) If the stock can close above its Jan.2004 H at 13.56 it seems it will be ready to resume its strong 2003 UPTREND. bigcharts.marketwatch.com On Jan.25 it announced that it received an order for 300 GeneXpert modules to be used in NOC's Biohazard Detection System to detect potential biological threats to the USPS. On an article today on Forbes on-line by Scott Gottlieb, MD,entitled "Biotechs vs. Bioterror" he states: "I believe the best new detection tools are being developed at Cepheid of Sunnyvale, Calif., which trades at $9.89 per share." forbes.com Bernard